Alteration of purinergic neurotransmission in isolated atria of streptozotocin-induced diabetic rats

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 2, 2012, Pages 158-164

  Musial, Diego Castro ^a,b   De Magalhães Galvão, Kleber ^a   Miranda Ferreira, Regiane ^a   Dantas Da Silva Júnior, Edilson ^a   Caricati Neto, Afonso ^a   Jurkiewicz, Neide Hyppolito ^a   Jurkiewicz, Aron ^a   Broetto Biazon, Ana Carla ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Integrado College of Campo Mourão   (Brazil)

Author keywords

isolated atria; purinergic neurotransmission; purinergic receptors; streptozotocin induced diabetic rats

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; GLUCOSE; LACTATE DEHYDROGENASE; PURINERGIC P2 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; URIDINE DIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HEART ATRIUM; HEART ATRIUM CONTRACTION; HEART FUNCTION; HEART RATE; INOTROPISM; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; HEART ATRIA; MALE; PURINERGIC AGONISTS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; STREPTOZOCIN; TIME FACTORS; URIDINE DIPHOSPHATE;

EID: 84857044516     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31823a0f31     Document Type: Article

References (53)

1. Jahansouz C, Kumer SC, Ellenbogen M, et al. Evolution of b-cell replacement therapy in diabetes mellitus: pancreas transplantation. Diabetes Technol Ther. 2011;13:395-418.
2. Okoshi K, Guimarães JFC, Muzio BP, et al. Miocardiopatia diabetic Arq Bras Endocrinol Metab. 2007;51:160-167.
3. World Health Organization. Diabetes. Available at: http://www.who.int/ mediacentre/factsheets/fs312/en/index.html. Accessed April 13, 2011.
4. Zelmanovitz T, Gerchman F, Balthazar AP, et al. Diabetic nephropathy. Diabetol Metab Syndr. 2009;1:10.
5. Meyers AJ, Shah RR, Gottlieb PA, et al. Altered toll-like receptor signaling pathways in human types 1 diabetes. J Mol Med. 2010;88: 1221-1231.
6. Baptista FL, Gaspar JM, Cristóvão A, et al. Diabetes induces early transient in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina. Brain Res. 2011; 1383:257-269.
7. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac beta adrenergic receptors, and heart failure. Circulation. 2000;101: 1634-1637. (Pubitemid 30196619)
8. Zhang J, Chang L, Chen C, et al. Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor. Cardiovasc Res. 2011;91:90-98.
9. Sharma V, Sharma A, Saran V, et al. b-Receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions. Eur J Pharmacol. 2011;657:117-125.
10. Burnstock G. Purinergic cotransmission. Brain Res Bull. 1999;50: 355-357.
11. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci. 2001;22:182-188. (Pubitemid 32244304)
12. Thaning P, Bune LT, Hellsten Y, et al. Attenuated purinergic receptor function in patients with type 2 diabetes. Diabetes. 2010;59:182-189.
13. Duarte JMN, Oses JP, Rodrigues RJ, et al. Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats. Neuroscience. 2007;159:382-391. (Pubitemid 47576547)
14. Howarth FC, Qureshi MA. Effect of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat. Mol Cell Biochem. 2006;289:21-29. (Pubitemid 44322471)
15. Otake H, Suzuki H, Honda T, et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50:627-641.
16. Gallego M, Alday A, Urrutia J, et al. Transient outward potassium channel regulation in healthy and diabetic hearts. Can J Physiol Pharmacol. 2009;87:77-83.
17. Froldi G, Pandolfo F, Chinellato A, et al. Dual effect of ATP and UDP on rat atria: which types of receptors are involved? Naunyn Schmiedebergs Arch Pharmacol. 1994;349:381-386. (Pubitemid 24110209)
18. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008;4:1-30.
19. Ulrich G, Boknik P, Schmitz W, et al. A positive inotropic effect of ATP in the human cardiac atrium. Am J Physiol Heart Circ Physiol. 2008;295: H1716-H1723. (Pubitemid 351492502)
20. Gergs U, Bokinik P, Schmitz W, et al. A positive inotropic effect of ATP in human cardiac atrium. Am J Physiol Heart Circ Physiol. 2008;295: H1191-H1197.
21. Wendemeyer H, Hofmann WP, Lueth S, et al. ALT screening for chronic liver diseases: scrutinizing the evidence. Z Gastroenterol. 2010;48:46-55.
22. Galvão KM. Participação dos purinoceptores nas disfunções cardíacas e autonômicas em animais geneticamente hipertensos. [Tese (Doutorado em Ciências)]. São Paulo, Brazil: Universidade Federal de São Paulo; 2009.
23. Wang YT, Takiguchi Y, Uematsu T, et al. Augmented responsiveness to sympathetic nerve stimulation of vas deferens of diabetic rats. Arch Int Pharmacodyn Ther. 1991;309:160-169.
24. Mamood N, Junejo AM, Jamal Q, et al. Association of visfatin with chronic kidney disease in a cohort of patients with and without diabetes J Pak Med Assoc. 2010;60:922-926.
25. Kaaja R. Vascular complications in diabetic pregnancy. Thromb Res. 2011;127(suppl 3):S53-S55.
26. Kain V, Kumar S, Puranik AS, et al. Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage. Cardiovasc Diabetol. 2010;9:1-9.
27. Urso C, Caimi G. Oxidative stress and endothelial dysfunction. Minerva Med. 2011;102:59-77.
28. Levin-Laina N, Laina A, Raz I. The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats. Diabetes Metab Res Rev. 2011;27:235-243.
29. Dobrzynski E, Montanari D, Agata J, et al. Adrenomodullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2002;283:E1291-E1298. (Pubitemid 35340637)
30. Maeda CY, Fernandes TG, Timm HB, et al. Autonomic dysfunction in short-term experimental diabetes. Hypertension. 1995;26:1100-1104.
31. Schaan BD, Maeda CY, Timm HB, et al. Time-course of changes in heart rate and blood pressure in rats with streptozotocin-induced diabetes treated with insulin. Braz J Med Biol Res. 1997;30:1081-1086. (Pubitemid 27425626)
32. De Angelis KLD, Oliveira AR, Dall'Ago P, et al. Effect of exercise training on autonomic and myocardial dysfunction in streptozotocindiabetic rats. Braz J Med Biol Res. 2000;33:635-641. (Pubitemid 30428606)
33. Tawfik HE, El-Remessy AB, Matragoons MAG, et al. Simvastatin improves diabetes-induced coronary endothelial dysfunction. J Pharmacol Exp Ther. 2006;319:386-395. (Pubitemid 44455146)
34. Usta CK, Adan G, Ozdem SS. The effects of adenosine on isolated right atrial preparations from streptozotocin-diabetic rats. J Auton Pharmacol. 2001;21:191-195. (Pubitemid 34592065)
35. Gür S. Effects of sodium selenate treatment on altered responses of left and right atria from streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol. 2004;44:9-15. (Pubitemid 38857123)
36. Ryu JK, Jantaratnotai N, Serrano-Perez MC, et al. Block of purinergic P2X7R inhibits tumor growth in a C6 brain tumor animal model. J Neuropathol Exp Neurol. 2011;70:13-22.
37. Matute C. Glutamate and ATP signaling in white matter pathology. J Anat. 2011;219:53-64.
38. Kenakin TP. The quantification of relative efficacy of agonist. J Pharmacol Methods. 1985;13:281-308.
39. Headrick JP, Lasley RD. Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol. 2009;193:189-214.
40. Wihlborg AK, Balogh J, Wang L, et al. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphates (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res. 2006;9:970-976.
41. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 2007; 64:1471-1483. (Pubitemid 46954150)
42. Duchen MR. Effects of NO on mitochondrial function in cardiomyocytes: pathophysiological relevance. Cardiovasc Res. 2006;1:10-21. (Pubitemid 43870058)
43. Zhao G, Zhang X, Xu X, et al. Depressed modulation of oxygen consumption by endogenous nitric oxide in cardiac muscle from diabetic dogs. Am J Physiol Heart Circ Physiol. 2000;279:H520-H527.
44. Sobrevia L, Mann GE. Dysfunction of the endothelial nitric oxide signaling pathway in diabetes and hyperglycaemia. Exp Physiol. 1997;82: 423-452. (Pubitemid 27234734)
45. Zhao G, Zhang X, Smith CJ, et al. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am J Physiol. 1999;277:H268-H278. (Pubitemid 29354702)
46. Dillmann WH. Diabetes mellitus induces changes in cardiac myosin in the rat. Diabetes. 1980;29:579-582. (Pubitemid 12180518)
47. Fein FS, Kornstein IB, Strobeck JE, et al. Altered myocardial mechanics in diabetic rats. Circ Res. 1980;47:922-933. (Pubitemid 11217058)
48. Legaye FP, Biegelman E, Deroubaix E, et al. Effect of 3,5,39- triiodothyronine treatment on cardiac action potential of streptozotocin- induced diabetic rat. Life Sci. 1988;42:2268-2274.
49. Nobe SM, Aomine M, Arita M, et al. Chronic diabetes mellitus prolong action potential duration of rat ventricular muscles: circumstantial evidence for impaired Ca2+ channel. Cardiovasc Res. 1990;24:381-389. (Pubitemid 20179589)
50. Tsuchida K, Watajima H. Potassium currents in ventricular myocytes from genetically diabetic rats. Am J Physiol Endocrinol Metab. 1997; 273:E695-E700.
51. Lagadic-Gossmann D, Chesnais JM, Feuvray D. Intracellular pH regulation in papillary muscle cells from streptozotocin diabetic rats: an ion sensitive microelectrode study. Pflügers Arch. 1988;412:613-617.
52. Bracken NK, Woodall AJ, Howarth FC, et al. Voltage-dependence of contraction in streptozotocin-induced diabetic myocytes. Mol Cell Biochem. 2004;261:235-243. (Pubitemid 39004536)
53. Yamamoto K, Kodama K, Masayuma T, et al. Role of atrial contraction and synchrony of ventricular contraction in the optimisation of ventriculoarterial couplings in humans. Br Heart J. 1992;67:361-367.